PharmAthene Wins Damages For Lost Profits In SIGA Row
A Delaware Chancery Court judge ruled Friday that PharmAthene Inc. is entitled to damages based on expected profits it would have earned from selling SIGA Technologies Inc.'s smallpox drug, following an...To view the full article, register now.
Already a subscriber? Click here to view full article